Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
Pheon Therapeutics
Iovance Biotherapeutics, Inc.
Travera Inc
Pfizer
Novartis
Pfizer
Turning Point Therapeutics, Inc.
Alterome Therapeutics, Inc.
Pfizer
NeoImmuneTech
ToLymph Inc.
Hoffmann-La Roche
Nuvectis Pharma, Inc.
AstraZeneca
Istituto Oncologico Veneto IRCCS
AstraZeneca
Avenzo Therapeutics, Inc.
Boehringer Ingelheim
Shanghai Pulmonary Hospital, Shanghai, China
AstraZeneca
Pheon Therapeutics
Auricula Biosciences Inc.
DualityBio Inc.